Medical Condition News

RSS

Pancreatic cancer shows distinct biological differences across racial groups

New research from the University of Cincinnati Cancer Center found biological differences in pancreatic cancer tumors and immune environments, opening the possibility for more personalized treatments for different populations.

6 Nov 2026

Ketamine may strengthen mindfulness therapy for opioid use disorder

Researchers from University of California San Diego School of Medicine have found that adding ketamine to a mindfulness-based treatment for opioid use disorder may strengthen people's ability to recognize and respond to signals from their bodies - changes that may help reduce opioid cravings.

6 Nov 2026

IITGN research explores new approach to tackling drug-resistant glioblastoma

Cancer remains among the most deadly diseases worldwide. Globally, more than 300,000 new cases of brain cancer are reported each year, with glioblastoma, an aggressive form of brain cancer, accounting for over 250,000 deaths.

6 Nov 2026

Harvard-led team receives $7 million to develop AI co-scientists for cancer research

A team led by Marinka Zitnik, associate professor of biomedical informatics in the Blavatnik Institute at Harvard Medical School, has received a grant of nearly $7 million from Cancer Grand Challenges to create artificial intelligence (AI) "co-scientists" that help cancer researchers analyze data, generate hypotheses, and suggest new experiments, speeding new knowledge and therapies.

6 Nov 2026

Stony Brook-developed cancer drug advances to human clinical trials

A promising new cancer chemotherapeutic agent from a taxane class of natural compounds – anti-cancer agents designed to block cell division and trigger the programmed cell death to treat sold tumors – originally developed by researchers at Stony Brook University has entered human clinical trials.

6 Nov 2026

Advanced tumor profiling uncovers hidden hereditary cancer-predisposition syndrome

Using next-generation sequencing (NGS) to profile tumor cells from patients with solid tumors, researchers at Fondazione Policlinico Universitario A. Gemelli IRCCS identified genetic alterations associated with cancer predisposition in 10% of the subjects examined.

6 Nov 2026

Rising grocery prices linked to higher food anxiety and insufficiency

As grocery prices continue to rise, a study by researchers at Penn State found that in addition to increased spending, the price hikes also are associated with higher risk of food insufficiency and worse mental health conditions.

6 Nov 2026

New review outlines role of extracellular vesicles in cancer and aging

A new review was published in Volume 13 of Oncoscience on September 30, 2026, titled "Extracellular vesicles in health, aging and disease."

6 Nov 2026

SCAI updates consensus framework for assessing cardiogenic shock severity

The Society for Cardiovascular Angiography & Interventions (SCAI) today released the 2026 SCAI SHOCK Classification Expert Consensus Update, providing refined guidance to help clinicians from diverse settings prioritize and recognize inadequate organ perfusion across a broad range of shock presentations, assess shock severity over time, and determine whether treatment is restoring adequate circulation.

6 Nov 2026

Study uncovers new shortcut mechanism behind cancer cell division

Living cells are one of the few materials that can replicate themselves, and this is crucial for tissue development and recovering from injury or illness.

6 Nov 2026

National MS Society funds research for earlier disease detection

The National Multiple Sclerosis Society is inviting researchers across a broad range of disciplines to apply for a new funding opportunity focused on advancing earlier detection of multiple sclerosis (MS).

6 Nov 2026

$Refractory lichen planus-like lesions reveal underlying systemic T-cell lymphoma$

Refractory lichen planus-like lesions reveal underlying systemic T-cell lymphoma

A 61-year-old man had a 2-year history of painful mucosal lesions and pruritic violaceous plaques on the trunk and extremities.

6 Nov 2026

UT MD Anderson announces major expansion to transform cancer care

The University of Texas MD Anderson Cancer Center today announced the historic expansion of its Texas Medical Center (TMC) campus through two new facilities: Inspiration Tower and Prism.

6 Nov 2026

Obesity drugs may help protect memory and cognitive abilities

Drugs used to treat obesity may also help protect the brain. In a review published in Science, researchers outline how a better understanding of these drugs' effects could lead to new treatments that protect memory and other important cognitive abilities.

6 Nov 2026

Women with Parkinson's have higher rates of Alzheimer's pathology

A new study is shedding light on how changes associated with different neurodegenerative diseases can overlap in the brain - and how that overlap may differ between women and men.

6 Nov 2026

Digital program boosts positive experiences for Chinese-American dementia caregivers

Chinese-American family caregivers of people with dementia reported a greater sense of control and competence in their caregiving roles and more positive views of caregiving after taking part in a seven-week digital support program, researchers at George Mason University found.

6 Nov 2026

Metal fumes, drinking habits and dementia: What a new study found

This study examines how workplace chemicals and lifestyle habits may influence Lewy body dementia risk, revealing potential sex differences in exposure effects.

6 Nov 2026

Towards a new approach to treating chronic blood disorders

A previously unrecognised weakness in the immune defenses against certain blood neoplasms could offer a promising target for future treatments.

6 Nov 2026

Doctors take minutes to measure heart function. AI takes seconds

The study indicates AI can enhance cardiac MRI analysis and mortality prediction, yet its clinical benefits and cost-effectiveness need further investigation.

6 Nov 2026

New European real-world evidence supporting Pepaxti in heavily pretreated multiple myeloma to be presented at ASH 2026

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that two abstracts highlighting real-world clinical outcomes for Pepaxti (melflufen) in relapsed, refractory multiple myeloma (RRMM) have been accepted for presentation at the 68th American Society of Hematology (ASH) Annual Meeting, taking place in New Orleans, USA, December 12–15, 2026.

6 Nov 2026